UroGen Pharma (URGN) Misses Q2 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: URGN) | Delayed: 29.75 -4.65 (13.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.40 | 52 Week High | $ | |||
| Open | $33.04 | 52 Week Low | $ | |||
| Day High | $34.17 | P/E | N/A | |||
| Day Low | $27.55 | EPS | $ | |||
| Volume | 1,488,044 | |||||
